Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
555.50    1.50 (0.27%)
Bid:
555.50
Ask:
556.00
Spread: 0.50 (0.09%)
Market Cap: £2.46b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

24 Nov 2017 12:54

Tate & Lyle PLC

Notification of transaction by Persons Discharging Managerial Responsibilities

Tate & Lyle PLC (the ‘Company’) announces that in accordance with the incentive arrangements relating to the recruitment of Melissa Law, President, Global Operations, and Andrew Taylor, President, Innovation and Commercial Development (who both joined the Company in September 2017) a grant of awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (‘Shares’) was made today as detailed in the table below:

Person discharging managerial responsibilities (‘PDMR’) Performance Share Plan (‘PSP’) Restricted Share Award (‘RSA’)
Melissa Law 150,491 22,597
Andrew Taylor 163,200 45,193

The PSP Award is subject to the performance conditions that apply to awards made under the Performance Share Plan 2012 during the year ending 31 March 2018 and accordingly will only vest to the extent that these performance conditions are satisfied by the Company over a three-year performance period which runs from 1 April 2017 to 31 March 2020. These criteria are described in the Annual Report 2017. No consideration is payable for the grant or release of the awards.

The notifications below, which have been made in accordance with the requirements of the EU Market Abuse Regulation, provide further detail.

Claire-Marie O’Grady

Company Secretary

24 November 2017

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Melissa Law
2. Reason for the notification
a) Position / status PDMR – President, Global Operations
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Restricted Share Award programme
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 173,088

d) Aggregated information

Aggregated volume Price

173,088

Nil

e) Date of the transaction 2017-11-24
f) Place of the transaction Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of PDMR / person closely associated with them (“PCA”)
a) Name Andrew Taylor
2. Reason for the notification
a) Position / status PDMR – President, Innovation and Commercial Development
b) Initial notification / amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Tate & Lyle PLC
b) LEI 2138008K14474WPKZ244
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument

Identification code

Ordinary shares of 25 pence each in the capital of Tate & Lyle PLC

GB0008754136

b) Nature of the transaction Grant of a conditional award over shares for no consideration under the Tate & Lyle Performance Share Plan 2012 and Restricted Share Award programme
c) Price(s) and volume(s)

Price(s) Volume(s)

Nil 208,393

d) Aggregated information

Aggregated volume Price

208,393

Nil

e) Date of the transaction 2017-11-24
f) Place of the transaction Outside a trading venue

View source version on businesswire.com: http://www.businesswire.com/news/home/20171124005128/en/

Copyright Business Wire 2017

Date   Source Headline
3rd Jul 20232:00 pmRNSTotal Voting Rights
3rd Jul 20237:02 amRNSDirectorate Change
29th Jun 20233:30 pmRNSHolding(s) in Company
28th Jun 20232:00 pmRNSHolding(s) in Company
7th Jun 20232:30 pmRNSDirector/PDMR Shareholding
6th Jun 202312:30 pmRNSAnnual Financial Report and Notice of AGM 2023
1st Jun 202312:00 pmRNSTotal Voting Rights
25th May 20237:00 amRNSFinal Results
18th May 20239:30 amRNSDirector Declaration
2nd May 20232:30 pmRNSTotal Voting Rights
4th Apr 202311:00 amRNSOperating Segment Restatement
3rd Apr 20234:15 pmRNSTotal Voting Rights
8th Mar 20232:30 pmRNSDirector/PDMR Shareholding
8th Feb 20237:00 amRNSCapital Markets Event
26th Jan 20237:00 amRNSTrading Statement
6th Jan 20232:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20233:17 pmRNSBlock listing Interim Review
8th Dec 20221:00 pmRNSDirector/PDMR Shareholding
30th Nov 20222:00 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSHalf-year Report
1st Nov 20223:15 pmRNSTotal Voting Rights
4th Oct 20228:25 amRNSCancellation of Preference Share Listing
3rd Oct 20222:45 pmRNSPref. share reduction effective & timetable update
29th Sep 20221:00 pmRNSTimetable update re. cancellation of pref. shares
14th Sep 202212:15 pmRNSHolding(s) in Company
13th Sep 20223:00 pmRNSCourt approval of cancellation of Pref. shares
10th Aug 20222:15 pmRNSDirector/PDMR Shareholding
4th Aug 20223:00 pmRNSDirector/PDMR Shareholding
2nd Aug 20224:00 pmRNSHolding(s) in Company
28th Jul 20221:00 pmRNSUpdate on Preference Share Reduction Timetable
28th Jul 202212:45 pmRNSResult of AGM
15th Jul 20225:20 pmRNSDirector/PDMR Shareholding
1st Jul 202210:45 amRNSBlock listing Interim Review
1st Jul 202210:17 amRNSTotal Voting Rights
29th Jun 20224:25 pmRNSDirector/PDMR Shareholding
29th Jun 20224:00 pmRNSDirector/PDMR Shareholding
24th Jun 20224:15 pmRNSHolding(s) in Company
23rd Jun 20223:00 pmRNSHolding(s) in Company
21st Jun 20222:30 pmRNSAnnual Financial Report and Notice of Meeting 2022
17th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20222:00 pmRNSHolding(s) in Company
15th Jun 20227:00 amRNSProposed Cancellation&Repayment Preference Shares
10th Jun 20222:00 pmRNSHolding(s) in Company
9th Jun 20227:06 amRNSAcquisition
9th Jun 20227:00 amRNSFinal Results
19th May 20225:00 pmRNSDirector/PDMR Shareholding
9th May 20222:23 pmRNSHolding(s) in Company
6th May 20222:46 pmRNSHolding(s) in Company
3rd May 20225:45 pmRNSHolding(s) in Company
3rd May 20228:01 amRNSShare Consolidation Effective Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.